SQNM is in a situation where it has started marketing its flagship test MaterniT21 for downs syndrome for expecting mothers. While its not 5 yet and has been above 25 recently and more than $400 during the hey days of genomics and internet bubble.
Last quarter it beat expectations, and will most definitely beat the coming quarter. Due to data mishandling a couple of years ago, WS hasn't forgiven this company. At 4 it has very little downside, but if the sales of their diagnostic tests keep rising as expected, the PPS will be 10-20 by the end of 2012.
Of course do you own DD, but the message board is weird and any post gets 200 one star rating in no time!! But if you own a few thousands of SQNM, I don't think you will be disappointed. I put big chunk of MITI profits into SQNM, we will see if it was wise or not.